Nicky Kelepouris
Overview
Explore the profile of Nicky Kelepouris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carmichael J, Kargi A, Dichtel L, Kelepouris N, Nedjatian N, Fridman M, et al.
J Endocr Soc
. 2025 Mar;
9(4):bvaf026.
PMID: 40078421
Adult growth hormone deficiency (AGHD) is a rare disease with both physiological and psychological effects for untreated patients. AGHD symptoms can improve over time with GH treatment. Here we have...
2.
Dauber A, Phillip M, Ferran J, Kelepouris N, Nedjatian N, Olsen A, et al.
Horm Res Paediatr
. 2024 Nov;
:1-12.
PMID: 39571543
Introduction: Children with idiopathic short stature (ISS) are known to have varying responses to growth hormone (GH) treatment (GHT). Methods: We conducted a post hoc analysis to identify clinical characteristics...
3.
Akhtar S, Berg B, Medina J, Gonczi M, Hamilton S, Hildebrand E, et al.
Med Devices (Auckl)
. 2024 Nov;
17:427-439.
PMID: 39493440
Purpose: Adherence to growth hormone treatment is known to affect growth outcomes. Both device preference and ease of use have been shown to affect treatment adherence. In this study, we...
4.
Miller B, Kelepouris N, Tenenbaum H, Di Carlo S, Backeljauw P
Growth Horm IGF Res
. 2024 Apr;
76:101592.
PMID: 38640825
Childhood growth hormone deficiency (GHD) is a rare disorder associated with significant burden on both patients and caregivers. Although previous reports have detailed aspects of the burden experienced by patients...
5.
Yuen K, Blevins L, Clemmons D, Faurby M, Hoffman A, Kelepouris N, et al.
Clinicoecon Outcomes Res
. 2024 Mar;
16:133-147.
PMID: 38476578
Purpose: Adult growth hormone deficiency (AGHD) is often underdiagnosed and undertreated, leading to costly comorbidities. Previously, we developed an algorithm to identify individuals in a commercially insured US population with...
6.
Alter C, Boguszewski M, Clemmons D, Dobri G, Geffner M, Kelepouris N, et al.
Growth Horm IGF Res
. 2024 Feb;
74:101573.
PMID: 38368660
Objective: Children with growth hormone deficiency (GHD) face multiple challenges that can negatively impact the transition from pediatric to adult endocrinology care. For children with GHD resulting from brain cancer...
7.
Cardenas J, Kelepouris N, Adiga R, Yuen K
BMC Med Educ
. 2024 Jan;
24(1):53.
PMID: 38200500
Background: Hypopituitarism, including growth hormone deficiency (GHD), is a common sequela of traumatic brain injury (TBI). This study explored the coverage of education and training of TBI-induced hypopituitarism in general...
8.
Biller B, Hoybye C, Ferran J, Kelepouris N, Nedjatian N, Olsen A, et al.
J Endocr Soc
. 2023 May;
7(6):bvad054.
PMID: 37197408
Context: Effectiveness and safety data on GH replacement therapy (GHRT) in older adults with adult GH deficiency (AGHD) are limited. Objective: To compare GHRT safety and clinical outcomes in older...
9.
Backeljauw P, Blair J, Ferran J, Kelepouris N, Miller B, Pietropoli A, et al.
J Clin Endocrinol Metab
. 2023 Mar;
108(10):2653-2665.
PMID: 36947589
Context: Despite having normal growth hormone (GH) secretion, individuals with Turner syndrome (TS) have short stature. Treatment with recombinant human GH is recommended for TS girls with short stature. Objective:...
10.
Ross J, Fridman M, Kelepouris N, Murray K, Krone N, Polak M, et al.
J Endocr Soc
. 2023 Mar;
7(5):bvad026.
PMID: 36936713
Context: Growth hormone (GH) therapy can increase linear growth in patients with growth hormone deficiency (GHD), Turner syndrome (TS), Noonan syndrome (NS), and Prader-Willi syndrome (PWS), although outcomes vary by...